| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_887606e16f425cf825d34fa2fe426d6b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6037
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-102 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P1-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-102 |
| filingDate |
2013-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6711e79ead9275f6a355e57427659649
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8590bd803fed340f3cccb11ce021a87b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e79bb3863c9b70e5c7b6aafbda5dfd6e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac8511b7b2cfd130b7e21e28de80f22c |
| publicationDate |
2018-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2644246-C2 |
| titleOfInvention |
Method for producing capsular haemophilus influenzae type b polysachharide, application of capsular polysaccharide and method for producing vaccine formulations |
| abstract |
FIELD: biotechnology. n SUBSTANCE: method of producing a capsular Haemophilus influenzae type b polysaccharide, application of the above mentioned capsular polysaccharide of for producing a vaccine formulation and method of producing a vaccine formulation. The method of producing capsular polysaccharide includes cultivation of Haemophilus influenzae type b strain in a cultural medium, collection and processing of the culture supernatant for extracting capsular polysaccharide. Moreover, the cultural medium contains zinc and does not contain a complex source of nitrogen or carbon. The method for producing the vaccine formulation comprises of the production of the above capsular polysaccharide and conjugation of the capsular polysaccharide with the carrier protein. n EFFECT: increase in the production of polysaccharide without increasing endotoxins. n 24 cl, 1 dwg, 11 tbl, 8 ex |
| priorityDate |
2012-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |